Table 1. . Antibacterial activities of compounds against staphylococcal strains.

Strains		Antibacterial activity of compounds (MIC, μg/ml)
Name	Type	OZE-I	OZE-II	OZE-III	Vancomycin	Oxacillin
Newman	MSSA	16	16	32	2	≤0.0625
MW2	MRSA	8	8	16	4	64
ATCC 29213	MSSA	8	8	16	2	0.5
ATCC 33591	MRSA	4	4	16	2	>64
USA100	MSSA	4	8	16	2	≤0.0625
USA300	MRSA	4	4	8	4	>64
USA400	MRSA	8	8	16	2	>64

MIC: Minimum inhibitory concentration; MRSA: Methicillin-resistant Staphylococcus aureus; MSSA: Methicillin-susceptible S. aureus; OZE-I: N-(5-(5,6,7,8-tetrahydronaphthalen-2-yl)-1,3,4-oxadiazol-2-yl) cyclopropanecarboxamide; OZE-II: N-(5-(3,5-dimethoxyphenyl)-1,3,4-oxadiazol-2-yl)-4-((4,4-dimethyloxazolidin-3-yl) sulfonyl) benzamide; OZE-III: N-(5-(4-chlorophenyl)-1,3,4-oxadiazol-2-yl) pentanamide.